Perfemed Group

[Ca United States ]

  • 1st
Business Type:
Manufacturer
Year Established:
1998
Total Revenue:
US$101 Thousand - US$500 Thousand
Main Markets:
North America, South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia

Company Description

Perfemed Group is established in San Francisco, US, with the goal of providing state-of-the-art medical products to homes, clinics, hospitals and other medical organizations. Its vision is to create the best environment for technological innovation, and to attract the best scientists, working together to provide health care solutions worldwide.

Its US Subsidiary, Chemux BioScience Inc., was established in 2005. It is comprised of a team of dedicated professionals with over 20 years' experience in the research, development and manufacture of immunoassays, specializing in recombinant antigens and immunodiagnostic reagents and assays on different platform technologies such as ELISA, Lateral flow and Flow through membrane tests, Microfluidic channel based assays, Western Blots, etc.

As a part of its global marketing strategy, Perfemed Group founded a GMP Manufacturing facility, its China Subsidiary, Perfect Ease Biotech Co., Ltd. in Beijing. Ever since its establishment, Perfect Ease have been striving to offer best unwavering quality and best clinical effectiveness in vitro diagnostic (IVD) products for varieties of disease panels market.

We export Elisa Reader, Microplate washer, ESR analyzer and ELISA Kits, such as Thyroid TSH, T3, T4, Prolactin, Progesterone, Estradiol, Testosterone, hCG, LH, FSH, Insuline, C-Peptide, HGH, CA-125, CA-199, CA-153, AFP, CEA, PSA, FPSA, HIV, HBV, HCV, Syphilis Elisa Kit etc..

Rapid Tests:

H. Pylori Antigen/Antibody, Dengue, HCG, Troponin-I, CK-MB, HIV, Syphilis, HCV, H. Pylori, MOR, THC, AMP, KET, COC,

Based on its technical expertise, reliable execution and collaborative policy, Perfemed Group will be easily recognized as a preferred and trusted partner for biotech companies and global distributors.